SUSTAINED INCREASE IN HEMOGLOBIN, HCT, AND RBC FOLLOWING LONG-TERM ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN TO PATIENTS WITH BETA-THALASSEMIA-INTERMEDIA
M. Aker et al., SUSTAINED INCREASE IN HEMOGLOBIN, HCT, AND RBC FOLLOWING LONG-TERM ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN TO PATIENTS WITH BETA-THALASSEMIA-INTERMEDIA, Blood, 82(10), 1993, pp. 10000358-10000358